John L. Erb is Director at VASCULAR SOLUTIONS INC (VASC). They have made 13 open-market trades across 5 companies since 2008, most recently 2025-06-10.
CIK 0001213867
7 open-market purchases totalling $213K since 2008, against 6 sales. Across 6 scored buys the stock is down 23.8% at ninety days, and 28.2 points behind the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 17% | 17% | 17% |
| Avg Move | +16.4% | +0.8% | -23.8% |
| Alpha | +15.4% | -1.6% | -28.2% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MIRO | BUY | 2023-03-10 | 2023-03-30 | $1.60 | $50K | -21.3% | -21.3% | +8.5% |
| CHFS | BUY | 2019-03-12 | 2019-03-12 | $5.25 | $50K | -19.3% | -10.0% | -32.9% |
| CHFS | BUY | 2018-07-03 | 2018-07-06 | $2.12 | $50K | -14.5% | -5.2% | -27.9% |
| SSH | BUY | 2016-11-28 | 2016-11-29 | $0.22 | $18K | +163.2% | +89.5% | -19.3% |
| VASC | SELL | 2016-04-28 | 2016-04-29 | $35.58 | $356K | +1.4% | +8.3% | +31.4% |
| SSH | BUY | 2016-03-16 | 2016-03-17 | $0.91 | $2K | -6.3% | -25.8% | -35.3% |
| SSH | BUY | 2016-03-14 | 2016-03-16 | $0.91 | $14K | -3.0% | -22.1% | -35.8% |
| VASC | SELL | 2015-02-18 | 2015-02-20 | $28.56 | $286K | -13.9% | -3.7% | -3.7% |
| VASC | SELL | 2013-11-07 | 2013-11-12 | $19.44 | $972K | -13.9% | -3.7% | -3.7% |
| VASC | SELL | 2012-05-18 | 2012-05-22 | $11.55 | $17K | -13.9% | -3.7% | -3.7% |
| VASC | SELL | 2009-02-09 | 2009-02-11 | $8.79 | $70K | -13.9% | -3.7% | -3.7% |
| SENO | BUY | 2008-11-26 | 2008-12-01 | $2.85 | $28K | N/A | N/A | N/A |
| VASC | SELL | 2008-07-28 | 2008-07-30 | $6.99 | $70K | -13.9% | -3.7% | -3.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| Total |
| $1.1M |
Shares reported on the most recent Form 4, priced at the 2025-06-11 close. 2 holdings could not be priced and are excluded from the total.